Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Depreciation and Depletion (2016 - 2026)

Avanos Medical's Depreciation and Depletion history spans 13 years, with the latest figure at $5.4 million for Q4 2025.

  • On a quarterly basis, Depreciation and Depletion rose 14.89% to $5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.7 million, a 2.96% decrease, with the full-year FY2025 number at $19.7 million, down 2.96% from a year prior.
  • Depreciation and Depletion hit $5.4 million in Q4 2025 for Avanos Medical, up from $5.0 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for AVNS hit a ceiling of $5.5 million in Q1 2021 and a floor of $700000.0 in Q4 2021.
  • Historically, Depreciation and Depletion has averaged $4.7 million across 5 years, with a median of $5.0 million in 2023.
  • Biggest five-year swings in Depreciation and Depletion: plummeted 88.33% in 2021 and later surged 500.0% in 2022.
  • Tracing AVNS's Depreciation and Depletion over 5 years: stood at $700000.0 in 2021, then surged by 500.0% to $4.2 million in 2022, then grew by 19.05% to $5.0 million in 2023, then dropped by 6.0% to $4.7 million in 2024, then increased by 14.89% to $5.4 million in 2025.
  • Business Quant data shows Depreciation and Depletion for AVNS at $5.4 million in Q4 2025, $5.0 million in Q3 2025, and $4.8 million in Q2 2025.